Arab Press

بالشعب و للشعب
Friday, Jun 20, 2025

Djokovic-backed ‘biotech’ firm’s approach likened to homeopathy

Djokovic-backed ‘biotech’ firm’s approach likened to homeopathy

Exclusive: QuantBioRes says it designs treatments for viral diseases based on electromagnetic frequency
A Danish “biotech” company in which Novak Djokovic holds a majority stake is working on a “frequency” treatment for 1Covid1-19 that an expert says bears similarities to the principles of homeopathy.

The world No 1 men’s tennis player was forced to leave Australia on Sunday after the country’s immigration minister cancelled his visa on the basis that his presence in Australia might risk “civil unrest” as he is a “talisman of anti-vaccination sentiment”.

On Wednesday it emerged Djokovic had acquired an 80% stake in QuantBioRes, the website of which says it designs treatments for viral diseases and resistant bacteria through “predicting the electromagnetic frequency” that can interfere with a virus’s activity.

“At QuantBioRes, we work in utilising unique and novel Resonant Recognition Model … a biophysical model based on findings that certain periodicities/frequencies within the distribution of energies of free electrons along the protein are critical for protein biological function and interaction with protein receptors and other targets,” the website says.

It carries a quote from the Serbian-American scientist Nikola Tesla: “If you wish to understand the universe, think of energy, frequency and vibration.”

Dr Darren Saunders, an Australian biomedical scientist, said the approach described on the QuantBioRes website was reminiscent of homeopathy, an alternative and unproven treatment that claims illness-causing substances can, in minute doses, treat people who are unwell.

Homeopaths claim that by diluting these substances in water or alcohol, the resulting mixture retains an “imprint” of “frequency” of the original substance that triggers a healing response in the body by causing an energetic shift.

Saunders said in his opinion it was “a stretch” for QuantBioRes to call itself a biotech company. “The ‘innovative technology’ they describe on their website does not reflect contemporary understanding of how biochemistry works,” Saunders said. “If any athletes or other potential investors would like advice on not blowing their cash on this stuff, my fees are reasonable.”

The website says the company will “soon start testing different treatment approaches”, but a link encouraging people to “learn more” appeared to be broken when the Guardian attempted to access it. A link to a July 2020 announcement that QuantBioRes would test 1Covid1-19 deactivation mechanisms also appeared to be broken.

Prof Peter Collignon, an infectious diseases physician and antimicrobial resistance expert, said the QuantBioRes website used “fancy terms” without providing any evidence of success of the methods it promoted. “They’ve given nothing in the way of data,” he said. “People are looking out for new molecules all the time, but the website describes a way of finding a new molecule without providing any evidence of success.”

The chief executive of QuantBioRes, Ivan Loncarevic, denied that the methods developed by his company had anything to do with homeopathy, and defended the lack of data on the company’s website.

“What we do has absolutely nothing to do with homeopathy,” he said in an interview. “The theory behind homeopathy is that you can transfer information from a chemical to another substance, such as water. What we do is to develop peptides with specific functionality. This is pure, classical science.

“Of course we are not putting our data on our website for every idiot to look at. We will soon publish an article in a scientific journal that will collect all our clinical testing.”

When asked when the article would be published, Loncarevic said: “With a little luck, in two to three months, after peer review.”

Asked about Saunders’ opinion that it was “a stretch” for QuantBioRes to call itself a biotech company and that the “innovative technology” described on its site did not reflect contemporary understanding of how biochemistry worked, Loncarevic replied: “That’s because we are innovative.”

He said other pioneers in engineering or science, such as Elon Musk and Galileo, had faced similar criticism when first airing their views. On the subject of broken links, he said this was the first time he had heard of the problem and “it’s not [done] on purpose”.
Newsletter

Related Articles

Arab Press
0:00
0:00
Close
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
G7 Leaders Fail to Reach Consensus on Key Global Issues
Mass exodus in Tehran as millions try to flee following Trump’s evacuation order
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Netanyahu Signals Potential Regime Change in Iran
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
Iran Conducts Ballistic Missile Launches Amid Heightened Tensions with Israel
Iran Signals Openness to Nuclear Negotiations Amid Ongoing Regional Tensions
Shock Within Iran’s Leadership: Khamenei’s Failed Plan to Launch 1,000 Missiles Against Israel
UK Deploys Jets to Middle East Amid Rising Tensions
Exiled Iranian Prince Reza Pahlavi Urges Overthrow of Khamenei Regime
Wreck of $17 Billion San José Galleon Identified Off Colombia After 300 Years
Iran Launches Extensive Missile Attack on Israel Following Israeli Strikes on Nuclear Sites
Israel Issues Ultimatum to Iran Over Potential Retaliation and Nuclear Facilities
Coinbase CEO Warns Bitcoin Could Supplant US Dollar Amid Mounting National Debt
Trump to Iran: Make a Deal — Sign or Die
Operation "Like a Lion": Israel Strikes Iran in Unprecedented Offensive
Israel Launches 'Operation Rising Lion' Targeting Iranian Nuclear and Military Sites
Israeli Forces Intercept Gaza-Bound Aid Vessel Carrying Greta Thunberg
IMF Warns of Severe Global Trade War Impacts on Emerging Markets
Syria to Reconnect to Global Economy After 14 Years of Isolation
Saudi Arabia Faces Uncertainty Over Succession After Mohammed bin Salman
Israel Confirms Arming Gaza Clan to Counter Hamas Influence
Majority of French Voters View Macron's Presidency as a Failure
U.S. Reduces Military Presence in Syria
Trump Demands Iran End All Uranium Enrichment in Nuclear Talks
Iran Warns Europe Against Politicizing UN Nuclear Report
Businessman Mauled by Lion at Luxury Namibian Lodge
Paris Saint-Germain's Greatest Triumph Is Football’s Lowest Point
OPEC+ Agrees to Increase Oil Output for Third Consecutive Month
Turkey Detains Istanbul Officials Amid Anti-Corruption Crackdown
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
European and Arab Ministers Convene in Madrid to Address Gaza Conflict
Head of Gaza Aid Group Resigns Amid Humanitarian Concerns
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
Iranian Revolutionary Guard Founder Warns Against Trusting Regime in Nuclear Talks
×